Focus on Diagnostics and Biomarkers

Published: 2015-11-19


On November 18, AIMday® Diagnostics & Biomarkers in Uppsala brought together academic researchers, industrial representatives and clinicians for discussions on this important and exciting subject. 

The AIMday concept is based on questions and topics from the industry that are prepared beforehand. Researchers will then sign up for sessions where they can offer their expertise.

Several SciLifeLab scientists joined the event, among them Tobias Sjöblom from Uppsala university, who participated for the fifth time.

– For me, these meetings are valuable and have led to three collaborations so far; a EU project, a larger project with industry and a smaller collaboration, said Tobias Sjöblom.

Correspondingly, industry representatives expressed their enthusiasm.

– This format is great for identifying potential partners for collaboration in the context of clinical trials, said first-time AIMday contributor Peter Klint, Scientific Advisor Oncology at Bristol-Myers Squibb.

To see the full program and discussed topics, visit: http://aimday.se/diagnostics-biomarkers-2015/